Idaho harm reduction project faces investigation and shutdown

In a recent government meeting, Monica Young, a manager with the Idaho Department of Health and Welfare, provided a detailed update on the Idaho Harm Reduction Project (IHARP) and the implications of the Syringe and Needle Exchange Act, which was passed in 2019. The act aimed to prevent disease transmission and reduce mortality among drug users, but its implementation has faced significant challenges.

Young reported that the department had conducted an extensive investigation into IHARP following police activity at its offices in February 2024. The investigation revealed a disconnect between the intent of the Syringe and Needle Exchange Act and its interpretation by department staff. While some staff viewed the act as endorsing broader harm reduction strategies, leadership interpreted it narrowly, leading to confusion over what supplies could be procured and reimbursed.

The investigation uncovered issues with the invoicing process, where IHARP submitted non-itemized invoices, making it difficult to track expenditures. Additionally, conflicts of interest were identified, as two department employees had affiliations with IHARP that were not disclosed in a timely manner.

Young outlined eight recommendations to improve oversight and management practices within the department, all of which were accepted by leadership. These include closing out syringe service programs in light of the act's repeal, enhancing training for staff on contract management, and implementing stricter document approval policies.

As of now, IHARP has ceased operations, and both of its sub-grants have been canceled. The department is now focused on addressing the identified issues to prevent similar occurrences in the future.